WebAug 10, 2024 · Goldfinch Bio, Inc. is a clinical stage biotechnology company focused on delivering disease-modifying precision medicines that bring hope and renewed quality of … WebFeb 28, 2024 · CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for …
Did you know?
WebMar 17, 2024 · Goldfinch Bio Scott Keys Current Workplace Scott Keys has been working as a Senior Director Head of Finance & Accounting at Goldfinch Bio for 3 years. Goldfinch Bio is part of the Business Services industry, and located in Massachusetts, United States. Goldfinch Bio Location 215 1st St Fl 4, Cambridge, Massachusetts, 02142, United States WebNov 20, 2024 · Caitlin Cornwall is a Senior Manager, Clinical Trial at Goldfinch Bio based in Cambridge, Massachusetts. ... Goldfinch Bio has added information to its read more company news. Read All. Infrastructure. Project. Feb 24 2024. Goldfinch Bio is planning to reduce the read more company news. Read All. Financial Planning.
WebDec 6, 2024 · CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced the appointment of Jeff W. Jacobs, Ph.D. as Chief Scientific Officer (CSO).Dr. Jacobs, who most recently served as CSO of Ardelyx, … WebJan 24, 2024 · Goldfinch Bio, Inc. is a clinical stage biotechnology company focused on delivering disease-modifying precision medicines that bring hope and renewed quality of life to people living with kidney diseases. We aspire to save kidneys and end dialysis.
WebJun 30, 2024 · Gilead-partnered Goldfinch Bio lands $100M as it pivots to clinical stage biotech Jason Mast Editor A year after landing $109 million in cash for an early-stage discovery deal with... WebOct 3, 2024 · Goldfinch Bio is leading a new age of therapeutic discovery and development in the kidney space, and is building the world's largest genomic registry of patients with kidney disease to inform...
WebFeb 28, 2024 · Anthony Johnson, M.D., President and Chief Executive Officer of Goldfinch Bio, commented, “We are pleased with the initial findings of clinical activity in our Phase 2 trial of GFB-887.
WebMar 17, 2024 · Eric Duhaime has been working as a Strategy Director, Product Planning at Goldfinch Bio for 3 years. Goldfinch Bio is part of the Business Services industry, and located in Massachusetts, United States. Goldfinch Bio Location 215 1st St Fl 4, Cambridge, Massachusetts, 02142, United States Description Read More Industry phoenix mountain preserve geologyWebOct 22, 2024 · Goldfinch Bio, Inc. is a clinical stage biotechnology company that leverages a genomics-based, precision medicine approach to discovering and developing kidney disease treatments. Its Kidney Genome Atlas (KGA™) is a proprietary biology platform that drives candidate discovery, biomarker development and patient selection. ttown dinerWebOct 15, 2024 · Goldfinch Bio, Inc. is a clinical stage biotechnology company focused on delivering disease-modifying precision medicines that bring hope and renewed quality of life to people living with kidney diseases. We aspire to save kidneys and end dialysis. t town dispensaryWeb215 First Street, 4th Floor Cambridge, MA 02142 We aspire to save kidneys and end dialysis by delivering disease-modifying precision medicines for patients. Page Transparency Goldfinch Bio, Inc. is responsible for this page. Page Manager Location United States About … 48 people like this 56 people follow this 1 person checked in here t town dispensary tulsaWebOct 22, 2024 · Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced for the first time results from its Phase 1 clinical trial evaluating GFB-887, a first-in-class highly potent and selective inhibitor of Transient Receptor Potential Canonical … t town donutsWebFeb 2, 2024 · BOSTON, February 02, 2024--Karuna Therapeutics, Inc. (NASDAQ: KRTX) and GFB (ABC), LLC, assignee of the Goldfinch Bio assignment estate, today … t town fenceWebAug 2, 2024 · Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, … phoenix movers yelp